Odonate Therapeutics, Inc. (ODT) [Rocket]

In millions, except per share items	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15
	10-K	10-K	10-K	10-K	10-K	S-1/A
Revenues	0.0	0.0	0.0	0.0	2.6	0.0
Revenue growth				-100.0%
Cost of goods sold	0.0	0.0	0.0	0.0	3.1	0.2
Gross profit	0.0	0.0	0.0	0.0	-0.5	-0.2
Gross margin					-17.7%
Selling, general and administrative [+]	10.4	10.9	10.8	4.8	0.5
General and administrative	10.4	10.9	10.8	4.8	0.5	0.0
Research and development	117.0	104.0	79.9	27.9
Other operating expenses					2.6
EBITDA [+]	-127.0	-114.5	-90.4	-32.7
EBITDA growth	10.9%	26.6%	176.3%	822.3%	2145.6%
EBITDA margin					-135.3%
Depreciation and amortization	0.4	0.4	0.4	0.0
EBIT [+]	-127.4	-114.9	-90.8	-32.7	-3.5	-0.2
EBIT growth	10.9%	26.6%	177.2%	822.9%	2145.6%
EBIT margin					-135.3%
Interest income			1.8
Interest income			1.8
Other income (expense), net [+]	1.1	3.1			0.5	0.2
Other non-operating income	1.1	3.1
Pre-tax income	-126.4	-111.8	-89.0	-32.7	-3.1	0.0
Income taxes	0.0	0.0	0.0	0.0	0.0	0.0
Tax rate	0.0%	0.0%	0.0%	0.0%	0.0%
Net income	-126.4	-111.8	-89.0	-32.7	-3.1	0.0
Net margin					-117.7%

Basic EPS [+]	($3.84)	($4.05)	($3.64)	($2.31)	($0.54)
Growth	-5.0%	11.3%	57.4%	331.6%
Diluted EPS [+]	($3.84)	($4.05)	($3.64)	($2.31)	($0.54)
Growth	-5.0%	11.3%	57.4%	331.6%

Shares outstanding (basic) [+]	32.9	27.6	24.5	14.2	5.8
Growth	19.0%	12.9%	72.6%	145.9%
Shares outstanding (diluted) [+]	32.9	27.6	24.5	14.2	5.8
Growth	19.0%	12.9%	72.6%	145.9%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.